Strategic Move Signals Expansion Beyond Oncology In a bid to broaden its portfolio and market footprint, Aurobindo Pharma is acquiring the non-oncology prescription business of Mumbai-based Khandelwal Laboratories Pvt Ltd. The transaction, carried out on a going concern, slump sale basis, is valued at Rs 325 crore in cash. This strategic move underscores Aurobindo’s intent…